|
BR112016011195A2
(pt)
|
2013-11-18 |
2017-09-19 |
Rubius Therapeutics Inc |
Células eritroides enucleadas e seus métodos de fabricação, composição farmacêutica e seu uso, uso de uma população de células eritroides, biorreator, mistura de células e dispositivo médico
|
|
CN106456744A
(zh)
|
2014-04-01 |
2017-02-22 |
鲁比厄斯治疗法股份有限公司 |
用于免疫调节的方法和组合物
|
|
CN108697733A
(zh)
*
|
2016-01-11 |
2018-10-23 |
鲁比厄斯治疗法股份有限公司 |
与癌症适应症的多模式治疗性细胞体系有关的组合物和方法
|
|
ES2987986T3
(es)
|
2016-06-10 |
2024-11-18 |
Gadeta B V |
Nuevo método para identificar cadenas de receptores de células T delta (o células T gamma) o partes de estas que intervienen en una respuesta antitumoral o antiinfecciosa
|
|
CN110520522A
(zh)
*
|
2017-02-17 |
2019-11-29 |
鲁比厄斯治疗法股份有限公司 |
功能化红系细胞
|
|
WO2019032628A1
(en)
|
2017-08-07 |
2019-02-14 |
The Regents Of The University Of California |
GENERATING PLATFORM FOR SAFE CELLULAR THERAPEUTIC AGENTS
|
|
US10960071B2
(en)
|
2017-08-07 |
2021-03-30 |
The Regents Of The University Of California |
Platform for generating safe cell therapeutics
|
|
EP3700334B1
(en)
|
2017-10-27 |
2026-04-08 |
Immunebridge Inc. |
Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene
|
|
WO2019090148A2
(en)
*
|
2017-11-03 |
2019-05-09 |
Rubius Therapeutics, Inc. |
Compositions and methods related to therapeutic cell systems for tumor growth inhibition
|
|
US12089930B2
(en)
|
2018-03-05 |
2024-09-17 |
Marquette University |
Method and apparatus for non-invasive hemoglobin level prediction
|
|
SG11202008261WA
(en)
*
|
2018-03-08 |
2020-09-29 |
Rubius Therapeutics Inc |
Therapeutic cell systems and methods for treating cancer and infectious diseases
|
|
WO2020028134A1
(en)
*
|
2018-07-30 |
2020-02-06 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for treating cancer
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
US11166996B2
(en)
|
2018-12-12 |
2021-11-09 |
Flagship Pioneering Innovations V, Inc. |
Anellovirus compositions and methods of use
|
|
CA3121528A1
(en)
|
2018-12-12 |
2020-06-18 |
Flagship Pioneering Innovations V, Inc. |
Anellosomes and methods of use
|
|
IL284878B2
(en)
|
2019-01-18 |
2026-04-01 |
Flagship Pioneering Inc |
TREM preparations and their uses
|
|
IL285110B2
(en)
*
|
2019-01-28 |
2025-11-01 |
Sanofi Sa |
Methods of treating multiple myeloma
|
|
CN121081491A
(zh)
|
2019-03-04 |
2025-12-09 |
旗舰创业创新第六有限责任公司 |
环状多核糖核苷酸及其药物组合物
|
|
JP7618577B2
(ja)
|
2019-03-25 |
2025-01-21 |
フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー |
修飾環状ポリリボヌクレオチドを含む組成物及びその使用
|
|
JP2022534988A
(ja)
|
2019-05-31 |
2022-08-04 |
フラッグシップ パイオニアリング, インコーポレイテッド |
tRNAプールを調節するためのTREMの使用
|
|
US20220257794A1
(en)
|
2019-06-14 |
2022-08-18 |
Flagship Pioneering Innovations Vi, Llc |
Circular rnas for cellular therapy
|
|
US12636369B2
(en)
|
2019-06-19 |
2026-05-26 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising circular polyribonucleotides for protein modulation and uses thereof
|
|
AR119906A1
(es)
|
2019-09-05 |
2022-01-19 |
Hemanext Inc |
Métodos para la conservación de glóbulos rojos reactivos utilizando monóxido de carbono
|
|
CN114555117A
(zh)
*
|
2019-10-12 |
2022-05-27 |
百奥泰生物制药股份有限公司 |
抗cd20抗体制剂及抗cd20抗体在治疗cd20阳性疾病中的应用
|
|
WO2021092073A1
(en)
|
2019-11-04 |
2021-05-14 |
Flagship Pioneering, Inc. |
Methods of modifying a nucleic acid sequence
|
|
CA3160097A1
(en)
|
2019-11-04 |
2021-05-14 |
Flagship Pioneering, Inc. |
Trem compositions for con-rare codons and related uses
|
|
TW202142689A
(zh)
|
2020-01-29 |
2021-11-16 |
美商旗艦先鋒創新有限責任公司 |
用於轉譯之組合物及其使用方法
|
|
EP4096681A1
(en)
|
2020-01-29 |
2022-12-07 |
Flagship Pioneering Innovations VI, LLC |
Delivery of compositions comprising circular polyribonucleotides
|
|
CN115279415A
(zh)
|
2020-01-29 |
2022-11-01 |
旗舰创业创新第六有限责任公司 |
用于蛋白调节的包含线性多核糖核苷酸的组合物及其用途
|
|
WO2021236952A1
(en)
|
2020-05-20 |
2021-11-25 |
Flagship Pioneering, Inc. |
Compositions and methods for producing human polyclonal antibodies
|
|
AU2021275223A1
(en)
|
2020-05-20 |
2023-02-02 |
Flagship Pioneering Innovations Vi, Llc. |
Coronavirus antigen compositions and their uses
|
|
IL298363A
(en)
|
2020-05-20 |
2023-01-01 |
Flagship Pioneering Innovations Vi Llc |
Immunogenic compositions and uses thereof
|
|
US20230203510A1
(en)
|
2020-05-29 |
2023-06-29 |
Flagship Pioneering Innovations Vi, Llc |
Trem compositions and methods relating thereto
|
|
EP4158032A2
(en)
|
2020-05-29 |
2023-04-05 |
Flagship Pioneering Innovations VI, LLC |
Trem compositions and methods relating thereto
|
|
EP4167984A1
(en)
|
2020-06-23 |
2023-04-26 |
Flagship Pioneering, Inc. |
Anti-viral compounds and methods of using same
|
|
IL300947A
(en)
|
2020-09-03 |
2023-04-01 |
Flagship Pioneering Innovations Vi Llc |
Immunogenic compositions and uses thereof
|
|
KR20230135585A
(ko)
|
2020-12-23 |
2023-09-25 |
플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 |
변형된 trem의 조성물 및 이의 용도
|
|
JP2024508456A
(ja)
*
|
2021-02-26 |
2024-02-27 |
サイトナス セラピューティクス,インク. |
治療的送達のための組成物および方法
|
|
JP2024510435A
(ja)
*
|
2021-03-18 |
2024-03-07 |
シージェン インコーポレイテッド |
生体活性化合物の内部移行複合体からの選択的薬物放出
|
|
EP4313109A1
(en)
|
2021-03-31 |
2024-02-07 |
Flagship Pioneering Innovations V, Inc. |
Thanotransmission polypeptides and their use in treating cancer
|
|
WO2022214707A1
(en)
*
|
2021-04-09 |
2022-10-13 |
Gadeta B.V. |
Cellular reporter and methods of using the same
|
|
WO2023009547A1
(en)
|
2021-07-26 |
2023-02-02 |
Flagship Pioneering Innovations Vi, Llc |
Trem compositions and uses thereof
|
|
AR127073A1
(es)
|
2021-09-17 |
2023-12-13 |
Flagship Pioneering Innovations Vi Llc |
Composiciones y métodos para producir polirribonucleótidos circulares
|
|
EP4419706A1
(en)
|
2021-10-18 |
2024-08-28 |
Flagship Pioneering Innovations VI, LLC |
Compositions and methods for purifying polyribonucleotides
|
|
MX2024006407A
(es)
|
2021-11-24 |
2024-08-19 |
Flagship Pioneering Innovations Vi Llc |
Composiciones de inmunogenos del virus varicela-zoster y sus usos.
|
|
IL312965A
(en)
|
2021-11-24 |
2024-07-01 |
Flagship Pioneering Innovations Vi Llc |
Immunogenic compositions and their uses
|
|
WO2023096990A1
(en)
|
2021-11-24 |
2023-06-01 |
Flagship Pioneering Innovation Vi, Llc |
Coronavirus immunogen compositions and their uses
|
|
EP4453201A1
(en)
|
2021-12-22 |
2024-10-30 |
Flagship Pioneering Innovations VI, LLC |
Compositions and methods for purifying polyribonucleotides
|
|
AU2022420620A1
(en)
|
2021-12-23 |
2024-07-04 |
Flagship Pioneering Innovations Vi, Llc |
Circular polyribonucleotides encoding antifusogenic polypeptides
|
|
WO2023220083A1
(en)
|
2022-05-09 |
2023-11-16 |
Flagship Pioneering Innovations Vi, Llc |
Trem compositions and methods of use for treating proliferative disorders
|
|
JP2025516638A
(ja)
|
2022-05-13 |
2025-05-30 |
フラッグシップ パイオニアリング イノベーションズ セブン,エルエルシー |
二本鎖dna組成物及び関連する方法
|
|
AU2023275550A1
(en)
|
2022-05-25 |
2024-11-21 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulating cytokines
|
|
KR20250019772A
(ko)
|
2022-05-25 |
2025-02-11 |
플래그쉽 파이어니어링 이노베이션스 Vii, 엘엘씨 |
종양 억제인자 및 발암유전자를 조절하기 위한 조성물 및 방법
|
|
CN119563038A
(zh)
|
2022-05-25 |
2025-03-04 |
旗舰创业创新七公司 |
用于调节免疫应答的组合物和方法
|
|
EP4650780A3
(en)
|
2022-05-25 |
2026-01-21 |
Flagship Pioneering Innovations VII, LLC |
Compositions and methods for modulating circulating factors
|
|
AU2023277636A1
(en)
|
2022-05-25 |
2024-11-21 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulating genetic drivers
|
|
EP4544043A1
(en)
|
2022-06-22 |
2025-04-30 |
Flagship Pioneering Innovations VI, LLC |
Compositions of modified trems and uses thereof
|
|
CN115368462B
(zh)
*
|
2022-07-19 |
2026-01-02 |
合肥天港免疫药物有限公司 |
双特异性抗体及其应用
|
|
WO2024077191A1
(en)
|
2022-10-05 |
2024-04-11 |
Flagship Pioneering Innovations V, Inc. |
Nucleic acid molecules encoding trif and additionalpolypeptides and their use in treating cancer
|
|
EP4612296A1
(en)
|
2022-10-31 |
2025-09-10 |
Flagship Pioneering Innovations VI, LLC |
Compositions and methods for purifying polyribonucleotides
|
|
US20260158161A1
(en)
*
|
2022-11-03 |
2026-06-11 |
Board Of Regents, The University Of Texas System |
An adjuvant and cd47-blockade combination cancer treatment and methods of using the same
|
|
WO2024102799A1
(en)
|
2022-11-08 |
2024-05-16 |
Flagship Pioneering Innovations Vi, Llc |
Compositions and methods for producing circular polyribonucleotides
|
|
TW202430215A
(zh)
|
2022-12-14 |
2024-08-01 |
美商旗艦先鋒創新有限責任(Vii)公司 |
用於將治療劑遞送至骨之組成物和方法
|
|
US20240238473A1
(en)
|
2023-01-09 |
2024-07-18 |
Beth Israel Deaconess Medical Center, Inc. |
Recombinant nucleic acid molecules and their use in wound healing
|
|
WO2024151687A1
(en)
|
2023-01-09 |
2024-07-18 |
Flagship Pioneering Innovations V, Inc. |
Genetic switches and their use in treating cancer
|
|
US20240252520A1
(en)
|
2023-01-09 |
2024-08-01 |
Beth Israel Deaconess Medical Center, Inc. |
Therapeutic agents and their use for treating chronic wounds
|
|
TW202446956A
(zh)
|
2023-02-17 |
2024-12-01 |
美商旗艦先鋒創新有限責任(Vii)公司 |
包含經修飾的胞嘧啶的dna組成物
|
|
KR20250151437A
(ko)
|
2023-02-17 |
2025-10-21 |
플래그쉽 파이어니어링 이노베이션스 Vii, 엘엘씨 |
변형된 우라실을 포함하는 dna 조성물
|
|
EP4680276A1
(en)
|
2023-03-15 |
2026-01-21 |
Flagship Pioneering Innovations VI, LLC |
Immunogenic compositions and uses thereof
|
|
EP4680750A1
(en)
|
2023-03-15 |
2026-01-21 |
Flagship Pioneering Innovations VI, LLC |
Compositions comprising polyribonucleotides and uses thereof
|
|
WO2024216128A1
(en)
|
2023-04-12 |
2024-10-17 |
Flagship Pioneering Innovations Vi, Llc |
Trems for use in correction of missense mutations
|
|
WO2025006684A1
(en)
|
2023-06-28 |
2025-01-02 |
Flagship Pioneering Innovations Vi, Llc |
Circular polyribonucleotides encoding antifusogenic polypeptides
|
|
WO2025042786A1
(en)
|
2023-08-18 |
2025-02-27 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising circular polyribonucleotides and uses thereof
|
|
WO2025096807A2
(en)
|
2023-10-31 |
2025-05-08 |
Flagship Pioneering Innovations Vii, Llc |
Novel therapeutic dna forms
|
|
US20260000702A1
(en)
|
2024-06-26 |
2026-01-01 |
Flagship Pioneering Innovations Vii, Llc |
Therapeutic circular dna forms
|
|
WO2026055543A1
(en)
|
2024-09-06 |
2026-03-12 |
Flagship Pioneering Innovations Vii, Llc |
Modified dna compositions and related methods
|
|
WO2026055547A1
(en)
|
2024-09-06 |
2026-03-12 |
Flagship Pioneering Innovations Vii, Llc |
Dna compositions and related methods
|
|
WO2026064313A1
(en)
|
2024-09-17 |
2026-03-26 |
Flagship Pioneering Innovations Vii, Llc |
Rna compositions and related methods
|
|
WO2026102108A1
(en)
|
2024-11-07 |
2026-05-15 |
Flagship Pioneering Innovations Vii, Llc |
Dna production methods
|
|
WO2026148005A1
(en)
|
2025-01-03 |
2026-07-09 |
Sail Biomedicines, Inc. |
Compositions and methods for purifying polyribonucleotides
|
|
WO2026151879A1
(en)
|
2025-01-10 |
2026-07-16 |
Flagship Pioneering Innovations Vii, Llc |
Vaccine compositions and methods
|
|
WO2026152164A1
(en)
|
2025-01-13 |
2026-07-16 |
Sail Biomedicines, Inc. |
Cd5-targeted lipid nanoparticles encapsulating polyribonucleotides encoding chimeric antigen receptors, and methods to generate car-expressing t cells in vivo
|